SynapDx was founded in Jan. 2010 to develop an innovative blood-based diagnostic test to aid in earlier detection of Autism Spectrum Disorders (ASD). We currently have 6 full-time employees. This opportunity will help us shape our brand identity as it is our first website build.
In the United States, 1 in 110 children will eventually be diagnosed with an ASD. Currently, the average age of diagnosis is 4.5 years, yet the average age of parental first concern is before age two. Currently, ASDs are diagnosed using a series of behavioral tests. SynapDx is developing blood-based approaches to help physicians more quickly identify those children most likely to have ASDs to enable earlier diagnosis and treatment. Earlier diagnosis and treatment are associated with better outcomes for these children and their families.
We are serious about doing good science and function in a relatively conservative space. As a group, we are serious and deliberate in our approach, yet also care deeply about helping physicians and families more efficiently navigate the path to diagnosis.
We do not yet have a product to market, but are instead focused on research. We want a website that conveys high quality professionalism and does not try to do too much since we are still very early in our company development. We will build out more in advance of product launch.